1 / 6

Central Nervous System Drugs Market Size, Growth, Opportunity and Forecast to 2030

Major Players in the Central Nervous System Drugs Market are Biogen Inc; F. Hoffmann-La Roche Ltd; Johnson & Johnson; Pfizer Inc; Novartis AG<br>Read More @ https://bit.ly/2TMogbF

sreeramakrishnatbrc
Download Presentation

Central Nervous System Drugs Market Size, Growth, Opportunity and Forecast to 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications And Growth www.tbrc.infoEmail: info@tbrc.info

  2. Introduction • The Business Research Company published its Central Nervous System Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market. The report covers the central nervous system drugs market’s segments- by type: analgesics; anti-Parkinson drugs; anesthetics; anti-epileptics; other CNS drugs, by distribution channel: hospital pharmacies; retail pharmacies/ drug stores; others, by route of administration: oral; parenteral; others, by drug classification: branded drugs; generic drugs, and by mode of purchase: prescription-based drugs; over-the-counter drugs. • The global central nervous system drugs market is expected to grow from $123.4 billion in 2019 to $136.7 billion in 2020 at a compound annual growth rate (CAGR) of 10.8%. This growth is mainly due to the COVID-19 outbreak and the neuroinvasive nature of the virus. The CNS is more prone to the viral infection. The virus affects the senses of smell and taste and therefore it is important to curb the interaction between the viral protein and the human receptor, and this factor is driving the demand for CNS drugs. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $160.4 billion in 2023. Click Here To View Complete Report www.tbrc.infoEmail: info@tbrc.info

  3. Table Of Content: • 1. Executive Summary • 2. Report Structure • 3. Central Nervous System Drugs Market Characteristics • 4. Central Nervous System Drugs Market Product Analysis • 5. Central Nervous System Drugs Market Supply Chain • ....... • 20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market • 21. Market Background: Pharmaceutical Drugs Market • 22. Recommendations • 23. Appendix • 24. Copyright And Disclaimer www.tbrc.infoEmail: info@tbrc.info

  4. Central Nervous System Drugs Market Global Companies Mentioned • Biogen Inc • F. Hoffmann-La Roche Ltd • Johnson & Johnson • Pfizer Inc • Novartis AG Click here to get a sample of this report www.tbrc.infoEmail: info@tbrc.info

  5. Follow us on our social media and message us! www.tbrc.infoEmail: info@tbrc.info

  6. Americas The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info Asia The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info

More Related